Appili Therapeutics is an anti-infective pharmaceutical development company.
Appili Therapeutics has raised $532K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2025.
Appili Therapeutics's investors include U.S. Department of War, The Lind Partners, Atlantic Canada Opportunities Agency, National Research Council of Canada Industrial Research Assistance Program, Innovacorp.
Appili Therapeutics is headquartered in Halifax, Canada.
Appili Therapeutics is an anti-infective pharmaceutical development company.
Appili Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Appili Therapeutics — Funding & Investors." VCBacked, November 5, 2025, https://www.vcbacked.co/company/appili-therapeutics. Accessed August 13, 2026.
VCBacked. (2025). Appili Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/appili-therapeutics
{{cite web |title=Appili Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/appili-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated